Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date - Quiz - MDSpire

Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date

  • By

  • Elise Van der Borght

  • Bart Van der Schueren

  • Roman Vangoitsenhoven

  • David Cassiman

  • Baris Akinci

  • Rebecca J. Brown

  • Elif A. Oral

  • Ann Mertens

  • Pieter-Jan Martens

  • May 13, 2026

Share

Original Source(s)

Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date

  • by Elise Van der Borght, Bart Van der Schueren, Roman Vangoitsenhoven, David Cassiman, Baris Akinci, Rebecca J. Brown, Elif A. Oral, Ann Mertens, Pieter-Jan Martens

  • May 13, 2026

Related Content

Ancient DNA Tracks 10,000 Years of Selection

Large dataset shows widespread genetic changes shaping modern traits and disease risk

  • May 12, 2026

  • 3 min
Remote Diet Support Studied in Diabetes

WhatsApp-based low-carbohydrate nutrition education was linked to short-term glycemic, weight, and medication-use improvements in a small primary care trial

Wearables May Boost T2D Mobility

Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.